Over the last 10 years ACI (Autologous Chondrocyte Implantation) has become an important surgical technique for treating large cartilage defects. The original method has been improved by using cell seeded scaffolds for implantation. The aim of our prospective study was to evaluate the efficiency of a matrix based ACI (MACI) with a collagen type I scaffold for repairing large cartilage defects of the knee. We present the clinical and radiological results of 22 pts. one year after collagen scaffold based ACI.

Out of 39 pts. treated with ACI for cartilage defects of the knee 22 had reached the one year follow up. We documented preoperatively and postoperatively (3, 6 and 12 months) the clinical situation with the IKDC Knee Examination Form. MRI scans were evaluated at all time points.

41% of the pts. were female, 59% male. The average age was 33 yrs. (min:15; max:49), the average BMI 25,4 (min:19; max:36). One third of the cartilage defects were localized retropatellar, the remaining on the medial or lateral femoral condyle. The average defect size was 5.7 cm2. In about 75% of the cases an additional surgical procedure was performed (ACL-reconstruction, lateral release, meniscal surgery). One major complication (a deep wound infection) occured. The IKDC score improved over time during follow up significantly. Patients with retropatellar defects have a poorer outcome compared to femoral defects. The MRI showed an improvement of the implanted scaffold over time as well.

The present study confirms the benefits of MACI in young patients with large cartilage defects of the knee. The matrix based ACI is a surgically less demanding technique then the traditional ACI. We expect a good long term outcome from MACI comparable to that of traditional ACI.

Irreparable tendon ruptures constitute a grave clinical problem. Especially for large rotator cuff tears, there often is no primary causal therapy available. As a sad result, the development of a rotator cuff tear arthropathy is more often than not inevitable. Our study investigates the effects of scaffold based tendon regeneration with special focus on mesenchymal stem cells in a rat model.

We used ‘native’ bone marrow stromal cells and cultivated mesenchymal stem cells from male rats that were implanted into female rats. As scaffolds polyglycol acid (PGA) and a collagen I were used. A full-thickness-defect of 2–3 mm in the middle third of the rats achilles tendon was created, which was then filled, with either cell-seeded or not cell-seeded scaffolds and, due to the low primary stability of the scaffolds, fixed with a 4-0 suture. After 12 weeks, a DNA PCR was conducted to verify the existence of male Y-chromosomes in the female regenerated tissue. We determined the maximum tensile load of the regenerated tissue and also did a histological evaluation.

Macroscopically the regenerated tendons were much bigger in diameter, much firmer and also much less elastic than a normal tendon. In the ‘mesenchymal stem cells’ group the implanted cells could be clearly identified after 12 weeks by DNA PCR. The collagen I scaffold yielded better results in the biomechanical study than the PGA scaffold. No evidence of positive influence of the cells on the mechanical stability of the regenerated tissue was found. Collagen I and the use of BMSC histologically lead to increased ossification of the regenerated tissue. In the PGA scaffold group a significant inflammatory reaction was found.

Both scaffold/cell combination seem to be unsuitable for tendon replacement. in-vitro studies on the influence of scaffold material on cell differentiation needs to be done.

One of the recently introduced anchors is the absorbable suture anchor BIOKNOTLESS-RC, a press-fit anchor whose special feature is the knotless reconstruction of the ruptured rotator cuff. We compared the new knotless anchor BIOKNOTLESS-RC with established anchors.

The absorbable pressfit anchor BIOKNOTLESS-RC (DePuyMitek, Raynham, MA, USA), the titanium screw anchor SUPER-REVO 5mm and the tilting anchor ULTRASORB (both ConmedLinvatec, Largo, FL, USA) were tested 12 times in the greater tuberosity of human cadaveric humeri (mean age: 74 years). They were inserted according to the manufacturers instructions with the supplied suture material. An incremental cyclic loading was performed, starting with 75N. Until failure the tensile load was increased by 25N after every 50 cycles. The ultimate failure loads, the anchor displacements and the modes of failure were recorded.

The anchor displacement of the BIOKNOTLESS-RC (15.3mm) after the first cycle with 75N was significantly higher than with the two others (SUPER-REVO 2.1mm, ULTRASORB: 2.7mm). The ultimate failure loads of the tested anchors were comparable: BIOKNOTLESS-RC 150N, SUPER-REVO 150N, ULTRASORB 151N (p> 0,05).

Rupture of the suture material at the eyelet occurred more frequently with the SUPER-REVO. BIOKNOTLESS-RC and ULTRASORB showed a tendency towards anchor pullout.

Our results do not confirm the higher pullout strength of metal anchors, which was found in other studies. Knotless anchors facilitate surgery by eliminating the technically challenging step of arthroscopic knot tying. The disadvantage of the BIOKNOTLESS-RC is its unsatisfactory primary stability. Its initial displacement of a mean of 15.3 mm is clinically significant and jeopardizes the rotator cuff repair.

Because of the high initial displacement and the possible gap formation between tendon and bone, the use of the BIOKNOTLESS-RC in a zone of minor tension, for instance as a second-row anchor in double row technique only is recommend.

Absorbable suture anchors have become more and more important in rotator cuff surgery due to their easy revisability. In osteoporotic bone however they are thought to be of minor primary stability. Purpose of the present study was to compare different absorbable and non-absorbable suture anchors in their pullout strength depending on bone density

The absorbable screw-anchor SPIRALOK5mm (DePuyMitek, Raynham, MA, USA), the titanium screw-anchor SUPER-REVO5mm and the tilting-anchor ULTRASORB (both ConmedLinvatec, Largo, FL, USA) were tested, each anchor representing a different material and design. On the basis of bone density measurement by CT-scans a healthy (mean-age. 42 years) and a osteopenic (mean-age: 74 years) group of cadaveric human humeri were formed. Each anchor was inserted in the greater tuberosity six times. They were inserted according to the manufacturers instructions with the supplied suture material. An incremental cyclic loading was performed, starting with 75N. Until failure the tensile load was increased by 25N after every 50 cycles. The ultimate failure loads, the anchor displacements and the modes of failure were recorded.

In the non-osteopenic bone group, the absorbable SPIRALOK achieved a significantly better pullout strength (mean: 274N) than the titanium screw-anchor SUPER-REVO (mean: 188N) and the tilting-anchor ULTRASORB (mean: 192N). In the osteopenic bone group no significant difference in the pullout strength was found. The failure mechanisms, such as anchor pullout, rupture at eyelet, suture breakage and breakage of eyelet, varied between the anchors. In the osteopenic group the number of anchor pullouts clearly increased.

The present study demonstrates that absorbable suture anchors do not have lower pullout strengths than metal anchors. Depending on their design they can even outmatch metal anchor systems. The results of our study suggest that the anchor design has a crucial influence on primary stability, whereas the anchor material is less important.